Jessica Simpson Selects Sequential Brands Group as Partner

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Jessica Simpson Selects Sequential Brands Group as Partner for the Jessica Simpson Collection
  • Sequential Brands Group Signs Definitive Agreement to Acquire Majority Interest in the Jessica Simpson Collection Brand

  • License with Camuto Group for Jessica Simpson Collection Footwear Being Extended Through New Long-Term Agreement

NEW YORK, April 2, 2015 (GLOBE NEWSWIRE) -- Sequential Brands Group, Inc. (Nasdaq: SQBG ) ("Sequential" or the "Company") announced today that it has signed a definitive agreement to acquire a majority interest in the Jessica Simpson brand, including the Jessica Simpson Collection master license and other rights. Brand Founder Jessica Simpson, who selected Sequential as her new business partner, will continue to own the balance of the equity. The transaction, which is expected to close within 90 days, is subject to customary closing conditions and regulatory approvals.

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=31868

Founded in 2005, the Jessica Simpson Collection is a signature lifestyle concept inspired by and designed in collaboration with Jessica Simpson. The growing brand offers 31 product categories including footwear, apparel, fragrance, fashion accessories, maternity apparel, girls clothing and a home line. The brand is supported by nearly 20 best-in-class licensees and has strong department store distribution through Dillard's, Macy's, Belk, Lord & Taylor and Nordstrom, among other independent retailers. Annual retail sales for the brand are approximately $1 Billion.

"I am extremely honored to partner with Sequential Brands Group to continue the growth and integrity of the Jessica Simpson Collection," said Ms. Simpson. "Working together with the powerful management team at Sequential and with all of our trusted retailers and licensees, including Camuto Group, there is no limit to our success.  I'm as committed as I was ten years ago.  Here's to the next billion."

Tina Simpson, Creative Director of The Jessica Simpson Collection, will continue to be an integral part of Ms. Simpson's LA based team.

"Jessica Simpson is an entertainment and style icon who successfully built an incredibly strong fashion brand with best-in-class licensees and leading retail partners," stated Yehuda Shmidman, CEO of Sequential. "Sequential is thrilled to partner with Jessica, her team and all the brand's licensing partners, including Camuto Group for footwear. Together with Sequential's global activation platform, we believe the brand will continue to grow in current markets and in new markets around the world."

Concurrently with the closing, Camuto Group's master license for the Jessica Simpson Collection will be replaced with a newly signed long-term license agreement to manufacture and distribute footwear. 

Alex Del Cielo, CEO of Camuto Group, commented, "We are excited to work with Sequential and to continue working closely with Jessica and the Jessica Simpson brand. We have enjoyed many years of success with Jessica and we are committed and looking forward to many more years ahead."

Financial Update :

Post-closing, the Company is projecting forward 12-month royalty revenues of $88.0 - $90.0 million and $53.5 - $55.0 million of Adjusted EBITDA from the Company's total brand portfolio.  Further guidance related to the fiscal year 2015 will be provided upon closing of the acquisition.

Other :

Sequential has obtained committed financing from Bank of America and GSO Capital Partners LP, an affiliate of Blackstone Group. The acquisition is expected to close within 90 days and is expected to be immediately accretive. 

David Levin of DL Business Management and Charles Grimes of Grimes, LLC were responsible for structuring the transaction on behalf of Ms. Simpson and advised Ms. Simpson on valuation, intellectual property and licensing matters.  Mitchell C. Littman of Littman Krooks LLP advised Ms. Simpson on corporate legal matters.

The deal team that represented Sequential during the acquisition was led by Tengram Capital Partners.  Gibson, Dunn & Crutcher LLP advised Sequential on the acquisition. White & Case LLP advised Sequential on the financing.

ABOUT SEQUENTIAL BRANDS GROUP, INC.

Sequential Brands Group, Inc. (Nasdaq: SQBG ) owns, promotes, markets, and licenses a portfolio of consumer brands in the fashion, active, and lifestyle categories. Sequential seeks to ensure that its brands continue to thrive and grow by employing strong brand management, design and marketing teams. Sequential has licensed and intends to license its brands in a variety of consumer categories to retailers, wholesalers and distributors in the United States and around the world. For more information, please visit Sequential's website at:  www.sequentialbrandsgroup.com . To inquire about licensing opportunities, please email:  newbusiness@sbg-ny.com . 

ABOUT THE JESSICA SIMPSON COLLECTION

The Jessica Simpson® Collection is inspired by and designed in collaboration with Jessica Simpson, entertainment, music and style icon.  This lifestyle collection reflects all that is modern Americana: it is iconic, fashion-forward, accessible, free-spirited, timeless and affordable.  The product offerings span 31 classifications – including footwear, outerwear, sunglasses, optical frames, handbags and handbag accessories, swimwear, perfume, legwear, scarves/hats/wraps, jewelry, intimates, slippers, cold weather accessories, luggage, dresses, jeanswear, sportswear, athleisure, fine jewelry, tween footwear, coats, swimwear, legwear and apparel, maternity apparel, toddler apparel.  The growing home product offerings include, bedding, towels and kitchen and bath accessories.  The collection, like Jessica herself, is classically familiar, approachable yet inspirational, sexy yet sweet, flirtatious and whimsical, vintage at times, but always of-the-moment.  The Jessica Simpson® Collection is currently available in over 2,500 points of distribution worldwide.

ABOUT CAMUTO GROUP

Camuto Group is a leading organization for design, development and distribution of women's fashion footwear. Renowned for its ability to develop lifestyle brands on a global scale, Camuto Group is building on the success of the Vince Camuto® and VC Signature Vince Camuto TM brands, extending into collections such as the recently introduced Louise et Cie® brand, Two By Vince Camuto® brand and a menswear line.  Camuto Group holds the footwear licenses for brands such as Jessica Simpson®, BCBGeneration®, BCBGMAXAZRIA® and Lucky Brand®.  Camuto Group's portfolio also includes the sourcing of footwear for Tory Burch®, as well as a partnership with Bernard Chaus.  Revered for its ability to design and source, Camuto Group and its partners operate 95 retail locations globally and products are sold in over 5,400 doors worldwide.

Forward-Looking Statements

Certain statements in this press release and oral statements made from time to time by representatives of the Company are forward-looking statements ("forward-looking statements") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date hereof and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. The Company's actual results could differ materially from those stated or implied in forward-looking statements. Forward-looking statements include statements concerning guidance, plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance or products, underlying assumptions and other statements that are not historical in nature, including those that include the words "subject to," "believes," "anticipates," "plans," "expects," "intends," "estimates," "forecasts," "projects," "aims," "targets," "may," "will," "should," "can," the negatives thereof, variations thereon and similar expressions.  Such forward-looking statements reflect the Company's current views with respect to future events, based on what the Company believes are reasonable assumptions. Whether actual results will conform to expectations and predictions is subject to known and unknown risks and uncertainties, including: (i) risks and uncertainties discussed in the reports that the Company has filed with the Securities and Exchange Commission; (ii) general economic, market, or business conditions; (iii) changes in the Company's competitive position or competitive actions by other companies; (iv) the Company's ability to maintain strong relationships with its licensees and retail partners; (v) the Company's ability to retain key personnel; (vi) the Company's ability to achieve and/or manage growth and to meet target metrics associated with such growth; (vii) the Company's ability to successfully attract new brands; (viii) the Company's ability to identify suitable targets for acquisitions; (ix) the Company's ability to obtain financing for the acquisitions on commercially reasonable terms; (x) the Company's substantial level of indebtedness, including the possibility that such indebtedness and related restrictive covenants may adversely affect the Company's future cash flows, results of operations and financial condition and decrease its operating flexibility; (xi) the Company's ability to integrate successfully the new acquisitions into its ongoing business; (xii) the Company's ability to achieve the anticipated results of these and other potential acquisitions; (xiii) the Company's largest stockholders control a significant percentage of the Company's common stock and appointed two members to the Company's board of directors, which may enable them to exert influence over corporate transactions and matters affecting the rights of the Company's stockholders; (xiv) the Company's ability to comply with government regulations; (xv) changes in laws or regulations or policies of federal and state regulators and agencies; and (xvi) other circumstances beyond the Company's control. Refer to section entitled "Risk Factors" set forth in the Company's Annual Reports on Form 10-K and the Company's Quarterly Reports on Form 10-Q for a discussion of important risks, uncertainties and other factors that may affect our business, results of operations and financial condition. The Company's stockholders are urged to consider such risks, uncertainties and factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Forward-looking statements are not, and should not be relied upon as, a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results will be achieved. As a result, actual outcomes and results may differ materially from those expressed in forward-looking statements. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Non-GAAP Financial Measures :

See reconciliation tables below for non-GAAP metrics. These non-GAAP metrics may be inconsistent with similar measures presented by other companies and should only be used in conjunction with our results reported according to U.S. GAAP. Any financial measure other than those prepared in accordance with U.S. GAAP should not be considered a substitute for, or superior to, measures of financial performance in accordance with U.S. GAAP.

The photo is also available at Newscom, www.newscom.com , and via AP PhotoExpress.

For media inquiries, contact :
Sequential Brands Group 
Jaime Cassavechia
212-518-4771 x108; jcassavechia@sbg-ny.com

Jessica Simpson
Lauren Auslander
212-373-6136; Lauren.auslander@pmkbnc.com

Non-GAAP Financial Measure Reconciliation
(in thousands, except per share data)
 
  (Unaudited)
  Projected Next Twelve Months
Post Closing (a)
  High Low
GAAP net income $ 14,067 $ 13,092
     
Adjustments:    
Interest expense, net 22,333 22,333
Depreciation and amortization 1,840 1,840
Taxes 7,576 7,051
Estimated deal costs and other (b) 3,500 3,500
Non-cash compensation - performance based awards (c) 3,434 3,434
Non-cash compensation - restricted stock (d) 2,250 2,250
  40,933 40,408
     
Adjusted EBITDA (1) $ 55,000 $ 53,500
     
     
  (Unaudited)
  Projected Next Twelve Months
Post Closing (a)
  High Low
     
GAAP net income $ 14,067 $ 13,092
     
Adjustments:    
Estimated deal costs and other (b) 3,500 3,500
Tax effect of above items (1,225) (1,225)
Total non-GAAP adjustments 2,275 2,275
     
Non-GAAP net income (2) $ 16,342 $ 15,367
     
     
  (Unaudited)
  Projected Next Twelve Months
Post Closing (a)
DILUTED EPS: High Low
     
GAAP earnings per share  $ 0.34  $ 0.32
     
Adjustments:    
Estimated deal costs and other (b)  0.08  0.08
Tax effect of above items  (0.03)  (0.03)
Total non-GAAP adjustments  $ 0.05  $ 0.05
     
Non-GAAP earnings per share (2)  $ 0.39  $ 0.37
     
   
RECONCILIATION OF TWELVE MONTH FORWARD GUIDANCE ADJUSTMENT: High Low
2015 EPS Guidance provided on November 6, 2014  $ 0.38  $ 0.35
Full Year accretion of acquisition  0.06  0.06
Projected Next Twelve Months Post Closing EPS   $ 0.44  $ 0.41
Non-cash compensation - performance based awards (c)  (0.05)  (0.05)
Projected Next Twelve Months Post Closing EPS - including Performance Based Awards (3)  $ 0.39  $ 0.37
     
(1) Adjusted EBITDA is defined as net income, excluding interest expense, taxes, depreciation and amortization, and excluding estimated deal costs and other and non-cash compensation. Management uses Adjusted EBITDA as a measure of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company's financial condition and results of operations. The Company believes Adjusted EBITDA provides additional information for determining its ability to meet future debt service requirements and capital expenditures.
(2) Non-GAAP net income and non-GAAP earnings per share are non-GAAP financial measures which represent net income excluding estimated deal costs and other. Management uses this information to measure performance over time on a consistent basis and to identify business trends relating to the Company's financial condition and results of operations. Management believes that these non-GAAP measures provide investors with information regarding the underlying performance of the Company's core business operating results on a cash basis.
(3) Amounts may not foot due to rounding.
(a) Projected next twelve months for after the acquisition closes. The acquisition is expected to close within the next 90 days. Because of the uncertainty of the closing date of the acquisition, the Company cannot estimate the financial impact on the current fiscal year 2015.
(b) Represents deal and other one-time costs related to the Company's acquisition transactions primarily related to legal, advisory and accounting costs that are not representative of the Company's day-to-day licensing business.
(c) Represents non-cash expenses related to (1) 210,500 performance based awards granted under the Company's 2013 Stock Incentive Compensation Plan and (2) 153,389 performance based awards for the 2015 portion granted under the Company's 2013 Stock Incentive Compensation Plan which the Company anticipates will be earned in 2015. Excludes (1) future mark-to-market adjustments to non-cash compensation provided to consultants for performance based awards and (2) 195,444 performance based awards which the Company does not anticipate will be earned at this time.
(d) Excludes future mark-to-market adjustments to non-cash compensation provided to consultants.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 147

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 114

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 19

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 139

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 72

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 147

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 141

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading

Top 5 Most Recently Viewed Articles

Trinseo Announces New Dividend Amid Strategic Changes Ahead

Updated Category News Views 225

Trinseo Approves Dividend for Shareholders Trinseo (NYSE: TSE), a prominent provider of specialty material solutions, has recently announced a quarterly dividend approved by its Board of Directors. The dividend declared stands at $0.01 per share, set to be distributed on a future date, offering a slight financial incentive for shareholders. To be eligible, shareholders...

Continue Reading
2026 Mighty 25: Celebrating Military Community Leaders

Updated Category News Views 26

A Spotlight on Unsung Heroes Tampa, Florida, just got a little mightier as We Are The Mighty rolls out the red carpet for the 2026 Mighty 25. This annual roll call, backed by CareSource Military & Veterans™, shines a light on veterans, military spouses, creators, entrepreneurs, and change agents defying the status quo. They are redefining impact across the military...

Continue Reading
Rubrik Inc Soars as Earnings Beat Expectations

Updated Category News Views 238

Rubrik Inc's Recent Stock Surge Rubrik, Inc. (NYSE: RBRK) has recently captured the attention of the market as its shares have risen over 20% following an impressive report of fourth-quarter earnings. The company exceeded expectations in both profitability and revenue, which undoubtedly prompted a wave of investor optimism. Financial Performance Highlights For the latest...

Continue Reading
Sanofi’s Amlitelimab Achieves Key Study Goals for Eczema Treatment

Updated Category News Views 284

Sanofi’s Amlitelimab Revolutionizes Atopic Dermatitis Treatment In an exciting development for patients suffering from atopic dermatitis, Sanofi's amlitelimab has met all primary and key secondary endpoints in the pivotal COAST 1 phase 3 study, targeting both adults and adolescents. This innovative medication demonstrated meaningful efficacy in terms of skin clearance...

Continue Reading
Alphamin Resources Corp: Board Changes and Future Outlook

Updated Category News Views 168

Leadership Changes at Alphamin Resources Corp Alphamin Resources Corp., a prominent player in the mining sector, recently shared significant news regarding its board of directors. The company announced the resignation of Mr. Rudolf Pretorius as a director. This change marks a pivotal moment in the company’s leadership structure, as Mr. Pretorius had been with the board...

Continue Reading